Episode 60
The initial public offering ((IPO) of Mankind Pharma Ltd opened for subscription on 25th April and closed just yesterday. The pharma major is reportedly eyeing a valuation of over $6.7 billion.
But in recent years, the Indian stock market has not been very kind to pharmas that have been listed. Since 2010, 17 of them have had IPOs, but four have delisted. Of the remaining, half are trading below their listing price.
Amidst this and the current economic state that is making many postpone their IPOs, Mankind still went ahead with its plan. Why?
Tune in to find out.
Published on 2 years, 8 months ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate